Drugs & TargetsFree FDA grants Mobocertinib Breakthrough Therapy Designation in NSCLC designation May 01, 2020Vol.46 No.18
Drugs & TargetsFree FDA grants accelerated approval for Trodelvy in previously-treated metastatic TNBC April 24, 2020Vol.46 No.17
Drugs & TargetsFree FDA approves first targeted treatment for patients with cholangiocarcinoma April 24, 2020Vol.46 No.17
Drugs & TargetsFree FDA approves mitomycin for low-grade upper tract urothelial cancer April 17, 2020Vol.46 No.16
Drugs & TargetsFree Ontruzant, biosimilar of Herceptin, introduced in the U.S. April 17, 2020Vol.46 No.16
Drugs & TargetsFree FDA approves Braftovi + cetuximab for BRAFV600E-mutant metastatic CRC indication April 10, 2020Vol.46 No.15
